Navigation Links
FDA Approves New Medicine BRILINTA™ (Ticagrelor) for Use in the US
Date:7/20/2011

WILMINGTON, Del., July 20, 2011 /PRNewswire/ -- AstraZeneca (NYSE: AZN) announced today that the US Food and Drug Administration (FDA) has approved BRILINTA™ (ticagrelor) tablets to reduce the rate of heart attack (myocardial infarction [MI]) and cardiovascular (CV) death in adult patients with acute coronary syndrome (ACS), compared to clopidogrel.

To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/astrazeneca/50355/

BRILINTA, a new oral antiplatelet medicine, is indicated to reduce the rate of thrombotic cardiovascular events in patients with ACS (unstable angina [UA] non-ST-elevation myocardial infarction [NSTEMI], or ST-elevation myocardial infarction [STEMI]). BRILINTA has been shown to reduce the rate of a combined endpoint of CV death, MI or stroke compared to clopidogrel. The difference between treatments was driven by CV death and MI with no difference in stroke. In patients treated with an artery-opening procedure known as percutaneous coronary intervention (PCI), BRILINTA reduces the rate of stent thrombosis. BRILINTA has been studied in ACS in combination with aspirin. Maintenance doses of aspirin above 100 mg decreased the effectiveness of BRILINTA. Avoid maintenance doses of aspirin above 100 mg daily.

David Brennan, Chief Executive Officer, AstraZeneca said: "The FDA approval of BRILINTA is good news for patients in the United States and represents a significant milestone as we seek to help ensure ACS patients around the world have access to this innovative medicine. With over one million people affected by ACS in the US each year, the fact that physicians have a new and more effective treatment option than clopidogrel to help reduce the rate of heart attack and cardiovascular death in these patients is an important adv
'/>"/>

SOURCE AstraZeneca
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Approves Vaccines for the 2011-2012 Influenza Season
2. FDA Approves Boostrix to Prevent Tetanus, Diphtheria, and Pertussis in Older People
3. FDA Approves Arcapta Neohaler to Treat Chronic Obstructive Pulmonary Disease
4. FDA Approves XARELTO® (rivaroxaban tablets) to Help Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery
5. FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
6. FDA Approves First Generic Versions of the Antibiotic Levofloxacin to Treat Certain Infections
7. FDA Approves Nulojix for Kidney Transplant Patients
8. FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment
9. FDA Approves First Ceramic-on-Metal Total Hip Replacement System
10. FDA Approves Redesigned Labels for Some Merck Drugs
11. FDA Approves Updates to Lillys Humalog® (insulin lispro injection [rDNA origin]) Label
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... DUBLIN , May 05, 2015 Research ... announced the addition of the "Clinical Laboratory,Molecular ... Forecasts 2015 to 2019 - Asia Pacific Version" ... market that just keeps on growing. Clinical laboratory ... explosion in biotechnology, especially genomics. A range of ...
(Date:5/5/2015)... , May 5, 2015  As cannabis prohibition ends one state at a time, more cannabis entrepreneurs are coming up ... idea phase, and the primary reason is lack of funding. ... ... ... ...
(Date:5/5/2015)... May 5, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... a randomized, double-blinded, placebo-controlled Phase 2 clinical trial ... ErbB3, in combination with nab-paclitaxel and gemcitabine, versus ... metastatic pancreatic cancer who have high serum levels ... the fourth leading cause of cancer death in ...
Breaking Medicine Technology:Asia Pacific Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Report 2015-2019 2Top Ten Ways Cannabis Startups are Getting Funded 2Top Ten Ways Cannabis Startups are Getting Funded 3Top Ten Ways Cannabis Startups are Getting Funded 4Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 2Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 3Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 4
... In response,to recent media speculation regarding the status of ... (TSE: 4568) and Eli,Lilly and Company (NYSE: LLY ... the FDA regarding the review of this application. The,companies ... the new drug,application (NDA) or of any decision to ...
... Inc. today announced,its EXCOR(R) Pediatric ventricular assist device (VAD) ... in the United,States of America. The U.S Food and ... the IDE study of the device., In 2007, ... study to begin initially at 10 centres with 10 ...
Cached Medicine Technology:Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application 2Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application 3Berlin Heart's EXCOR(R) Pediatric Receives Unconditional Investigational Device Exemption (IDE) Approval 2Berlin Heart's EXCOR(R) Pediatric Receives Unconditional Investigational Device Exemption (IDE) Approval 3
(Date:5/5/2015)... California (PRWEB) May 05, 2015 On ... Downtown Los Angeles, CA, Choices Recovery sponsored Durkin Entertainment’s ... Durkin, LA’s leading producer of sustainable product placement in ... of the world’s top providers of ecologically sound and ... a premier red carpet event that makes appearances at ...
(Date:5/5/2015)... Oklahoma (PRWEB) May 05, 2015 Don’t ... the money for a fitness membership? Don’t know which ... of these obstacles in order to help members achieve ... life. Live Streaming Fitness, an educational, caused-based wellness company, ... offers live streaming fitness classes led by certified trainers, ...
(Date:5/5/2015)... Major League Ultimate (MLU) was founded by ... Frisbee™ is home to many amazing athletes, dramatic moments, ... world. Nike Ultimate Camps’ goal of spreading the sport ... athletes to learn about the sport and develop their ... , The Nike Ultimate Camp in Philadelphia by MLU ...
(Date:5/5/2015)... Igantia , an emerging biotechnology ... international initiative to examine key biological milestones during a ... Scientists at Igantia believe that better understanding of ... of her menstrual cycle to her transition into menopause, ... ultimately, extend the lifespan. , By recently announcing ...
(Date:5/5/2015)... After record-breaking sales of Extend Nutrition’s ... Cookies & Cream flavor at stores nationwide this month. ... raised the bar for nutritional snacks. The brand ... nutritional profile, backed by international patents and clinical studies. ... additional new products and expand retail availability throughout 2015. ...
Breaking Medicine News(10 mins):Health News:Choices Recovery Mishawaka Talks About Overcoming Adversity with Actor Matthew Ziff at the “RockNRolla Movie Awards” EcoLuxe Lounge 2Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 2Health News:Live Streaming Fitness Creates Industry Shift by Bringing Fitness, Nutrition and Cooking Classes to Smart Devices 3Health News:US Sports Camps, Nike Ultimate Camps, and Major League Ultimate Host Youth Ultimate Summer Camps in Philidelphia 2Health News:Igantia Announces Digital Initiative to Decode Longevity 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4
... BIRMINGHAM, Ala., May 8 HealthSouth,Corporation (NYSE: HLS ... among other things, elect directors and provide an update ... May 2007., More than 88.5% of the outstanding ... in person or by proxy and the board,s,nominated slate ...
... NutraCea (OTC Bulletin Board:,NTRZ), a world leader in ... today that it will release its first quarter,financial ... closes., Management will host the conference call ... the first quarter financial results for 2008 and ...
... Shortly after the gruesome,discovery of aborted babies in ... early March, Citizens for a Pro-Life Society,discovered the mutilated ... Clinic in Livonia, Michigan, owned by Dr. Reginald Sharpe., ... in which we live that we,must stop and take ...
... Healthcare ... Reforms - ,Medicare for All, OAKLAND, Calif., ... America -- and the nation,s largest union of RNs,-- Bill ... fight for guaranteed,single-payer healthcare in an episode scheduled to air ...
... death, study finds , , THURSDAY, May 8 (HealthDay News) -- ... a stethoscope over a main artery to the brain could ... heart disease and stroke, a new study finds. , The ... caused by turbulent blood flow due to buildup of fatty ...
... of Hematology (ASH) is proud to announce the selection ... Award Program (MMSAP), which encourages minority medical students to ... each award recipient will receive the support of a ... to attend medical meetings, and a subscription to the ...
Cached Medicine News:Health News:HealthSouth Board Re-Elected at Annual Shareholder Meeting 2Health News:NutraCea to Host First Quarter 2008 Conference Call on May 12. 2Health News:ALL: More Dead Babies Found in Michigan Dumpsters 2Health News:Bill Moyers' Journal to Feature California Nurses Association/National Nurses Organizing Committee in Friday, May 9th Episode 2Health News:Noise in Artery Could Warn of Heart Risk 2Health News:Minority medical students receive support to increase diversity in hematology 2
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
Medicine Products: